Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington’s disease-Reference-Cited by-同舟云学术

Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington’s disease

Published:2023-02-16 Issue:5 Volume:7 Page:629-646
ISSN:2157-846X
Container-title:Nature Biomedical Engineering
language:en
Short-container-title:Nat. Biomed. Eng

Author:

Yan Sen,Zheng Xiao,Lin Yingqi,Li Caijuan,Liu Zhaoming,Li Jiawei,Tu Zhuchi,Zhao Yu,Huang Chunhui,Chen Yizhi,Li Jun,Song Xichen,Han Bofeng,Wang Wei^ORCID,Liang Weien,Lai Liangxue^ORCID,Li Xiao-Jiang,Li Shihua^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Computer Science Applications,Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology

Link

https://www.nature.com/articles/s41551-023-01007-3.pdf

Reference77 articles.

1. Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005 (2015).

2. Shulman, J. M., De Jager, P. L. & Feany, M. B. Parkinson’s disease: genetics and pathogenesis. Annu. Rev. Pathol. 6, 193–222 (2011).

3. Sims, R., Hill, M. & Williams, J. The multiplex model of the genetics of Alzheimer’s disease. Nat. Neurosci. 23, 311–322 (2020).

4. Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180–186 (2016).

5. Bunting, E. L., Hamilton, J. & Tabrizi, S. J. Polyglutamine diseases. Curr. Opin. Neurobiol. 72, 39–47 (2022).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the current status of CRISPR based clinical trials for rare diseases;International Journal of Biological Macromolecules;2024-10

2. Molecular therapy for polyQ disorders: from bench to clinical trials;Trends in Molecular Medicine;2024-09

3. CRISPR/Cas9-mediated neuronal deletion of 5-lipoxygenase alleviates deficits in mouse models of epilepsy;Journal of Advanced Research;2024-09

4. Circadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review;Biomedicines;2024-08-06

5. In vivo evaluation of guide-free Cas9-induced safety risks in a pig model;Signal Transduction and Targeted Therapy;2024-07-19